Drug Pricing Avoids The Limelight During State Of The Union Address
Executive Summary
President Trump did not offer any new proposals on drug pricing during an evening featuring campaign theatrics on both sides.
You may also be interested in...
Trump Administration Signals Deference To Congress On Drug Pricing Policy
In a marked departure from previous years, budget proposal offers few specifics on cost reductions, but the $135bn savings estimate is a tacit endorsement of the Grassley-Wyden bill in the Senate.
Medicaid Demo’s Formularies Include Protections For HIV, Behavioral Health Drugs
Healthy Adult Opportunity initiative (don’t call it block grants) adopts some, but not all, of Medicare Part D’s protected classes, allowing states to exclude some drugs from coverage in the expansion Medicaid population to drive additional savings.
US Drug Pricing Legislation Efforts Headed Toward Spring Renewal? A Look Ahead
Senate legislation taking aim at price increases faces uphill climb, but sponsors are hoping President Trump will mobilize more support among congressional Republicans in the coming year.